SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories gets nod for commencing manufacturing unit in South Sikkim

31 May 2019 Evaluate

Alkem Laboratories has received approval from its board for commencement of manufacturing unit in South Sikkim from June 1, 2019. While, the company will close two units situated at Nani Daman in the state of Gujarat and another unit situated at East Sikkim respectively.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5529.60 -68.95 (-1.23%)
12-May-2026 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.20
Dr. Reddys Lab 1273.00
Cipla 1303.55
Zydus Lifesciences 936.40
Lupin 2255.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×